Regenerative Medicine and Cellular Therapies
Regenerative medicine is a class of medicine geared toward restoring tissue or organs that may have been damaged. “Cellular therapy” is a broad term that refers to treatments that involve the use, modification, or support of cells to restore or improve function in the body. Stem cell treatment falls under both categories–regenerative medicine and cellular therapy–along with a variety of other therapies such as exosome therapy, mitochondrial cellular therapies, peptide therapy, IV nutrition, and autologous cell therapy.
What Is Stem Cell Therapy?
There is a growing number of stem cell therapies. Sometimes they are categorized by their source, i.e., from where the stem cells were harvested, or their cell line, or the types of conditions they help treat or prevent. They have been shown to lower inflammation, regulate the immune system, and support tissue/cellular regeneration. The handling of stem cells can influence people’s comfort with their use, their perceived value of safety and efficacy, and be a source of controversy. A company that offers stem cells should have proof of meeting GMP (Good Manufacturing Processes) for quality assurance.
Childhood conditions such as autism are often accompanied by symptoms of inflammation, immune dysregulation and body dysfunctions that can be difficult to treat. Although stem cell therapy is less widely used, or available, in pediatrics, it is becoming more popular. Some parents are now seeking stem cell therapy for autism and other conditions. When considering stem cell therapy as a viable or effective option for yourself or a loved one, it may be helpful to familiarize yourself with the different types and conditions treated.
Where Do Stem Cells Come from?
Human stem cells generally come from bone marrow, peripheral blood and the umbilical cord. However, there are many sources and types of stems cells in use for different purposes (including plant stem cells high in antioxidants). Below is a list of the more well-known human stem cells and their uses:
- Mesenchymal Stem Cells (MSC) come from bone marrow, adipose (fat) tissue, or umbilical cord. They are anti-inflammatory, immune-modulating, and tissue-regenerating. They have been used for autism spectrum disorder (ASD) to reduce neuroinflammation and improve communication between brain and immune cells, autoimmune diseases such as lupus, multiple sclerosis, and rheumatoid arthritis, orthopedic injuries such as osteoarthritis, tendon and ligament repair, and chronic inflammation such as inflammatory bowel disease (IBD).
- Neural Stem Cells (NSC) come from fetal brain tissue or induced pluripotent stem cells (iPSCs) and can differentiate into neurons and glial cells. The are commonly used for neurodegenerative diseases such as Parkinson’s, Alzheimer’s, ALS, and spinal cord injuries to support nerve regeneration, and for stroke recovery to promote neural repair.
- Hematopoietic Stem Cells (HSCT) come from the bone marrow, peripheral blood, or umbilical cord blood and form all blood cell types. They are are used to “reset” the immune system, including their use in blood cancers such as leukemia, lymphoma, and multiple myeloma, for severe autoimmune diseases such as multiple sclerosis (MS), systemic sclerosis, and genetic blood disorders like sickle cell anemia and thalassemia.
- Perinatal and Umbilical Cord-Derived Stem Cells come from Wharton’s jelly, cord blood, or cord tissue and are rich in MSCs and growth factors, with less risk of immune rejection. They are more commonly used in conditions like cerebral palsy to support motor and brain function, for autism and developmental delays for their anti-inflammatory and neuro-supportive mechanisms, arthritis and joint pain to regenerate and support, wound healing and tissue regeneration
- Induced Pluripotent Stem Cells (iPSC) are harvested from adult cells (e.g., skin or blood) and reprogrammed back into stem cells. They can become almost any cell type, potentially customizable to the individual (mostly involved in research and clinical trials for now). These may become useful in addressing genetic disorders, modeling and potentially correcting mutations, and retinal diseases such as macular degeneration, as well as cardiac repair post heart attack, or diabetes to create insulin-producing beta cells.
- Adult or Adipose-Derived Stem Cells come from bone marrow or fat tissue (via liposuction) and are like MSCs, with regenerative and anti-inflammatory benefits. These cells are more widely used in the areas of osteoarthritis and joint injuries, chronic pain and inflammation, skin rejuvenation, wound healing, and Crohn’s disease or other inflammatory conditions.
- Embryonic Stem Cells (ESCs) come from three-to-four-day-old embryos which may hold the most powerful medical potential, but they are also highly controversial for ethical and religious reasons.
Can Parents Trust Stem Cells?
This is a serious question for informed consumers and based on multiple factors, including educational resources, GMP status (see above), accessibility and possible travel costs, along with accessibility of alternative therapies with similar benefits. Doctors and other healthcare providers do not have the final say in whether a family chooses to proceed; parents must decide which direction they will take with each child. Such decisions can feel overwhelming, like stepping out on a limb and hoping for the best. Sometimes other parents who have taken a decisive step can provide helpful insights too. Parents who have children with autism often must work hard to find hopeful solutions for their child’s symptoms. This is true when it comes to stem cell therapy too.
Are Stem Cells Appropriate for Autism?
Keep in mind that children with autism are not all the same even though they share the same diagnoses and some of the same symptomology. Every child with autism is different with different genetics, different SNPs, different nervous system development, different etiology of symptoms (possibly hypo- or hyperactive or a combination), different capabilities, different developmental milestones, and so on and so forth. As the saying goes, “if you meet one child with autism, you have met one child with autism.”
Genetic factors, immune factors, sensory issues, nervous-system tolerance, a child’s ability to stay calm and still, or tolerate injections, or cooperate or follow directions etc. these are all operative in a decision like doing stem cell therapy. Moreover, the right stem cell therapy may not be available in the United States or Canada; a family might have to fly to another country or a very different environment than the child is accustomed to being in.
As with many challenging neurologic conditions, parents of children with autism must also consider a whole host of factors that could impact the efficacy of a specialized therapy such as stem cells:
- Maintaining the best diet
- Interrupting or forgoing other therapies, or adding others that are synergistic
- Dealing with the increase of sensory overload
- Making sure the child can sleep at night and eat during the day, or at best cooperate, and the list goes on and on.
What Are Stromal Cells?
One type of adult stem cells called Mesenchymal Stem Cells (MSCs) are also known as Mesenchymal Stromal Cells due to their capabilities of presenting as multipotent stromal cells which can separate into various types of cells such as bone, cartilage, fat, cells and connective tissues. It is this unique factor of MSCs that gives this type of stem cell the notoriety of tissue repair and regeneration which is why they are important to regenerative medicine.
Why Mesenchymal Stem Cells?
MSCs are very distinct stem cells with very special properties, and they can effectuate change which makes them the most sought-after stem cells for autism. There are several characteristics of these stem cells that separate them from other stem cells. Firstly, they can be isolated and cultured very easily from various tissues like bone marrow, adipose (fat or lipid) tissue, and umbilical cord which makes them accessible. Their availability in many types of tissues is another positive reason why mesenchymal stem cells are the stem cell of choice. The fact that they are adult stem cells is yet another positive factor because they do not raise any ethical issues as with embryonic stem cells.
MSCs also have many properties to modulate the immune system which is a very important factor for children diagnosed with autism. Furthermore, MSCs have a very low risk of rejection by the immune system. Due to all these unique factors and their potential to repair tissues and organs that have been damaged, MSCs have been instrumental for regenerative medicine. MSCs are also used in many orthopedic conditions such as osteoarthritis and bone fractures. Similarly, the cardiovascular field is looking at the potential of MSCs to repair damaged heart tissue. Equally importantly, MSCs are being investigated and applied to treat neurological disorders, autoimmune diseases, and other neurodegenerative conditions in many countries other than the United States.
Autism and Mesenchymal Stem Cells
What is so special about MSCs for children with autism? There are several reasons why MSCs may possibly be the most effective choice of stem cell therapy for children with autism. MSCs:
- Have the capacity to proliferate
- Are neuroprotective
- Can reduce ongoing inflammation in the brain
- Are neuroprotective
- Can migrate to injured tissue in the brain and repair
- Can promote cellular growth in damaged areas of the brain
- Can single out and differentiate damaged neurons
- Can replace and repair damaged neurons
- Can convert from one type of cell to another when needed
- Can increase the production of neurotropic factors (GDNF & BDNF)
- Can promote vascular blood supply to the nervous system
- Can stimulate a new generation of blood cells as required
- May increase cognitive functioning
- Can modulate the immune system
- Can repair immune system deregulation
- Can stop the neuro-destructive process typical to autism in the brain
- Can promote neuronal growth and connectivity
- Can stimulate vascular stimulating growth factors
- May increase language and language development May improve social awareness
- May improve personal growth and development
- May increase interest in peer relationships
- May improve emotional responses
- May increase overall better quality of life
Looking at all these benefits can undoubtedly inspire autism parents to rethink what they are doing with their child with autism and possibly consider mesenchymal stem cells. Undoubtedly, it does seem very promising; however, many parents have travelled overseas to Panama and other locations outside of the United States and Canada and returned disappointed when their child did not make all the gains that they had expected, especially when there is such an extensive financial commitment involved.
Even though there are never any guarantees with any therapy for autism, what is most important for parents is to be aware of the many issues involved when planning and deciding. I strongly urge every parent possibly contemplating this therapy for their child to please read this article that informs parents of exactly what to be prepared for.
Need for Studies
Another concern that needs attention is the fact that there is more and more research coming out about the possible long-term risks associated with this therapy. Long-term studies and observations need to be done to investigate the negative effects of MSCs long term, even though they initially seem to be overall very promising and impressive from the results of the clinical studies done so far.
What has been observed by researchers is that stem cells — when cultured for several generations — heighten the possibility of mutation in the stem cells that unfortunately tends to behave like cancer cells. This may lead to the formation of lumps or tumors caused by uncontrolled growths. In addition to this, there is also the possibility of contamination from viruses found in these cultured stem cells that could be transferred to the patients. These are risk factors that parents should take into consideration when making decisions about stem cell therapy.
In the United States, the FDA will only allow regenerative medicine therapies to be part of a registered clinical trial. All U.S. trials can be found at clinicaltrials.gov or on the website of Parent’s Guide to Cord Blood. Currently, the only clinical trials being offered for autism in North America are those at Duke University. Here is one documented research study in Switzerland on the mesenchymal cells and children on the autism spectrum.
Possible Alternatives
Currently, there is a growing interest in plant-based stem cells and in plants that have remarkable capacity to promote our own stem-cell production and distribution, which seem to be a safer, less-invasive choice with fewer concerns. Modern medical technology also makes it possible to study and verify these plants’ profound effect on the human body. We are learning not only how important the number of stem cells are in our bodies for tissue restoration, repair and maintenance, but also how plants can promote stem cells, provide biodiversity, are safe for humans, are eco-friendly, and are readily available in the natural environment. These special stem-cell promoters come from plant extracts that contain very high concentrations of antioxidants. For instance, Chinese herbs such as panax ginseng and panax notoginseng have the capacity to assist in the production and diversity of neural and mesenchymal stem cells in the body.
Vitamin C also plays a role, as it has the capacity to naturally increase stem cells in the body and is involved in the generation and maintenance of stem cells.
In Conclusion
To all parents considering this therapy for their child with autism: do your due diligence and make informed choices.
About Heather Tallman Ruhm MD
Heather Tallman Ruhm MD is the Medical Director of the Documenting Hope Project. She is a Board Certified Family Physician whose primary focus is whole-person health and patient education. She draws on her conventional western training along with insights and skills from functional, integrative, bioregulatory and energy medicine. She believes in the healing capacities of the human frame and supports the power of self-regulation to help her patients recover and access vitality.

About Teresa Badillo
In the 1980s she worked overseas in Rome, Italy at the Japanese Embassy in the office of the United Nations (FAO) as a speech writer. She also began her long journey in alternative healing while living in Rome.
After moving to New York and while raising her family of seven children, Teresa embarked on a mission to find alternative non-invasive biomedical, therapeutic, sensory and educational solutions for autism after the diagnosis of her son in the early 1990s.

She won a court case in 1995 against the Rockland County School District in New York to enable ARC Prime Time for Kids to be the first school using Applied Behavioral Analysis teaching method for autism that was paid for by the Rockland County School District. The following year she was instrumental in getting the New York Minister of Education to approve an extension of the ARC license from 5 to 21 years.
She has worked over the years in a number of alternative medical practices with doctors and practitioners organizing various biomedical intervention options for children with autism. Since the mid 1990s, Teresa has served on several boards:
- Foundation for Children with Developmental Disabilities
- The Autoimmunity Project
- Developmental Delayed Resources
- Epidemic Answers
She continues to consult and advise parents on all different areas of autism especially nutritional protocols. Since 2006 she has worked with NutraOrgana, LLC and BioCellular Analysis Testing. She currently researches, writes the newsletter and blogs Teresa’s Corner for The Autism Exchange (AEX). She also writes blog posts and pages for Documenting Hope.
Still Looking for Answers?
Visit the Documenting Hope Practitioner Directory to find a practitioner near you.
Join us inside our online membership community for parents, Healing Together, where you’ll find even more healing resources, expert guidance, and a community to support you every step of your child’s healing journey.
Sources & References
Aggarwal, S., et al. Plant stem cells and their applications: special emphasis on their marketed products. 3 Biotech. 2020 Jun 5;10(7):291.
Akiyama, Y., et al. Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J Neurosci. 2002 Aug 1;22(15):6623-30.
Amoh, Y., et al. Multipotent hair follicle stem cells promote repair of spinal cord injury and recovery of walking function. Cell Cycle. 2008 Jun 15;7(12):1865-9.
Bickford, P.C., et al. Nutraceuticals synergistically promote proliferation of human stem cells. Stem Cells Dev. 2006 Feb;15(1):118-23.
Borlongan, C.V., et al. Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats. Brain Res. 2004 Jun 4;1010(1-2):108-16.
Chen, J., et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke. 2001 Nov;32(11):2682-8.
Chopp, M., et al. Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport. 2000 Sep 11;11(13):3001-5.
Contreras, J.L., et al. Peripheral mobilization of recipient bone marrow-derived endothelial progenitor cells enhances pancreatic islet revascularization and engraftment after intraportal transplantation. Surgery. 2003 Aug;134(2):390-8.
Dezawa, M., et al. Potential of bone marrow stromal cells in applications for neuro-degenerative, neuro-traumatic and muscle degenerative diseases. Curr Neuropharmacol. 2005 Oct;3(4):257-66.
Ding, D.C., et al. Mesenchymal stem cells. Cell Transplant. 2011;20(1):5-14.
Drapeau, C., et al. Rapid and selective mobilization of specific stem cell types after consumption of a polyphenol-rich extract from sea buckthorn berries (Hippophae) in healthy human subjects. Clin Interv Aging. 2019 Feb 4:14:253-263.
Emmons, R., et al. Exercise as an Adjuvant Therapy for Hematopoietic Stem Cell Mobilization. Stem Cells Int. 2016:2016:7131359.
Fang, J., et al. Melatonin prevents senescence of canine adipose-derived mesenchymal stem cells through activating NRF2 and inhibiting ER stress. Aging (Albany NY). 2018 Oct 25;10(10):2954-2972.
Hasegawa, Y., et al. Bone marrow (BM) transplantation promotes beta-cell regeneration after acute injury through BM cell mobilization. Endocrinology. 2007 May;148(5):2006-15.
He, F., et al. Ginsenoside Rg1 as a Potential Regulator of Hematopoietic Stem/Progenitor Cells. Stem Cells Int. 2021 Dec 31:2021:4633270.
Jensen, G.C., et al. The use of in situ bone marrow stem cells for the treatment of various degenerative diseases. Med Hypotheses. 2002 Oct;59(4):422-8.
Kaneko, Y., et al. Bone marrow-derived stem cell therapy for metastatic brain cancers. Cell Transplant. 2015;24(4):625-30.
Li, C., et al. The potential of plant extracts in cell therapy. Stem Cell Res Ther. 2022 Sep 14;13(1):472.
Li, Y., et al. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology. 2002 Aug 27;59(4):514-23.
Liu, Q., et al. Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders. World J Stem Cells. 2019 Feb 26;11(2):55-72.
Marchesi, C., et al. Skin-derived stem cells transplanted into resorbable guides provide functional nerve regeneration after sciatic nerve resection. Glia. 2007 Mar;55(4):425-38.
Mezey, E., et al. Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1364-9.
Mias, C., et al. Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Stem Cells. 2008 Jul;26(7):1749-57.
Musiał-Wysocka, A., et al. The Pros and Cons of Mesenchymal Stem Cell-Based Therapies. Cell Transplant. 2019 Jul;28(7):801-812.
Nishino, H., et al. Restoration of function by neural transplantation in the ischemic brain. Prog Brain Res. 2000:127:461-76.
Painovich, J., et al. A Randomized, Controlled Pilot Study of the Effects of Acupuncture on Circulating Endothelial Progenitor Cells in Coronary Heart Disease. Integr Med (Encinitas). 2014 Apr;13(2):27-33.
Qian, X.D., et al. [Proliferation and differentiation of human CD34+ hematopoietic stem/progenitor cells induced by Panax notoginosides]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003 Apr;11(2):120-3.
Qu, J., et al. Efficacy and Safety of Stem Cell Therapy in Children With Autism Spectrum Disorders: A Systematic Review and Meta-Analysis. Front Pediatr. 2022 May 4:10:897398.
Peterson, D.A. Stem cells in brain plasticity and repair. Curr Opin Pharmacol. 2002 Feb;2(1):34-42.
Siniscalco, D., et al. Mesenchymal stem cells in treating autism: Novel insights. World J Stem Cells. 2014 Apr 26;6(2):173-8.
Tamouza, R., et al. Possible Effect of the use of Mesenchymal Stromal Cells in the Treatment of Autism Spectrum Disorders: A Review. Front Cell Dev Biol. 2022 Jul 5:10:809686.
Voltarelli, J.C., et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA. 2007 Apr 11;297(14):1568-76.
Wu, S., et al. Neural stem cells improve learning and memory in rats with Alzheimer's disease. Pathobiology. 2008;75(3):186-94.
Zhang, J., et al. [Study on Panax notoginseng mobilizing marrow stem cells efferens efficiency of acute myocardial infarction in rats]. Zhongguo Zhong Yao Za Zhi. 2009 Apr;34(7):893-5.
Zheng, H., et al. Total saponins of Panax notoginseng enhance VEGF and relative receptors signals and promote angiogenesis derived from rat bone marrow mesenchymal stem cells. J Ethnopharmacol. 2013 Jun 3;147(3):595-602.
Resources
Articles
Everything parents should know about stem cell therapy for Autism. Parent’s Guide to Cord Blood Foundation, May 2019.
Fetyukhina, Aleksandra. Mesenchymal Stem Cell Infusions for Children with ASD: Swiss Medica Research Study Results. SwissMedica, 26 Jun 2024.
Stem cell therapy. RaisingChildren.net.au. Accessed 14 Apr 2025.
Stem Cell Therapy for Autism. Beike Biotechnology. Accessed 14 Apr 2025.
The Story of Christian Drapeau and the Birth of STEMREGEN. STEMREGEN. Accessed 14 Apr 2025.